Related Experiment Video
Updated: Jul 10, 2025

Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
The p53/ZEB1-PLD3 feedback loop regulates cell proliferation in breast cancer
Bo-Wen Liu1,2,3,4, Ning Sun1,2,3,4,5, Hui Lin1,2,3,4,6
1The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Phospholipase D3 (PLD3) inhibits breast cancer cell proliferation by binding to CDK1, causing mitotic arrest. This mechanism involves PLD3 and miR-6796 regulation by p53 and ZEB1, impacting DNA methylation.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading global health concern, particularly for women.
- Phospholipase D3 (PLD3), a member of the phosphodiesterase family, is implicated in tumor development via the AKT pathway.
- Understanding PLD3's role in breast cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the molecular mechanism by which PLD3 inhibits breast cancer cell proliferation.
- To investigate the co-expression and regulatory relationship between PLD3 and miR-6796 in breast cancer.
Main Methods:
- Investigated the co-expression of PLD3 and miR-6796 in breast cancer tissues.
- Examined the interaction between PLD3 and CDK1, and its effect on cell proliferation.
- Analyzed the regulatory roles of p53, ZEB1, and DNMT3B in the PLD3/miR-6796 pathway, including DNA methylation.
Main Results:
- PLD3 and miR-6796 were found to be co-expressed in breast cancer.
- PLD3 directly binds to and inhibits CDK1 expression, inducing mitotic arrest and suppressing proliferation.
- A regulatory network involving p53, ZEB1, miR-6796, and DNMT3B controls PLD3 and miR-6796 expression via promoter DNA methylation.
Conclusions:
- PLD3 and its embedded microRNA, miR-6796, play a significant role in regulating breast cancer cell proliferation.
- The study reveals a novel molecular mechanism involving PLD3, CDK1, p53, ZEB1, miR-6796, and DNMT3B.
- These findings offer potential therapeutic targets and prognostic markers for breast cancer treatment.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity

